Arthrogenic lameness of the fetlock: synovial fluid markers of inflammation and cartilage turnover in relation to clinical joint pain.

REASONS FOR PERFORMING THE STUDY Joint pain is one of the most common causes of lameness in the horse but its pathogenesis is poorly understood. OBJECTIVES To investigate which synovial fluid markers may be related to the presence of clinically detectable joint pain in the horse. METHODS Concentrations of structural (CPII, C2C, GAG) and inflammatory markers (PGE2, LTB4, CysLTs, bradykinin and substance P) were measured in fetlock joint fluid from 22 horses in which lameness was localised to the fetlock region by perineural anaesthesia. Levels of these markers were then compared in horses that responded (n = 15) to those that did not (n = 7) to subsequent intra-articular anaesthesia (IAA). RESULTS Of all markers analysed, only substance P levels were significantly higher (P = 0.0358) in synovial fluid of horses that showed a positive response to IAA compared to those with a negative response to IAA. Notably, while PGE2 levels were found to be elevated in all 22 lame horses compared to sound controls (P = 0.0025), they were not related to the response to IAA. CONCLUSIONS While levels of PGE2 are elevated in synovial fluid of lame horses that respond to perineural anaesthesia, only substance P is related to joint pain as detected by the response to intra-articular anaesthesia. POTENTIAL RELEVANCE Substance P is associated with clinically detectable joint pain in the horse. Elevated levels of PGE2 in fetlock-lame horses, regardless of their response to IAA, indicate that either this mediator does not reflect intra-articular pain or that IAA might have limitations in differentiating between intra- and peri-articular sources of pain. Either way, a negative response to IAA may not exclude intra-articular pathology.

[1]  D. Larhammar,et al.  Pharmacological characterization of ligand–receptor interactions at the zebrafish bradykinin receptor , 2005, British journal of pharmacology.

[2]  A. Barneveld,et al.  The influence of repeated arthrocentesis and exercise on matrix metalloproteinase and tumour necrosis factor alpha activities in normal equine joints. , 2010, Equine veterinary journal.

[3]  D. Kaplan,et al.  Matrix Metalloproteinases and Their Clinical Applications in Orthopaedics , 2004, Clinical orthopaedics and related research.

[4]  C. McIlwraith,et al.  Correlation of prostaglandin E2 concentrations in synovial fluid with ground reaction forces and clinical variables for pain or inflammation in dogs with osteoarthritis induced by transection of the cranial cruciate ligament. , 2004, American journal of veterinary research.

[5]  T. Spoormakers,et al.  Diagnostic anaesthesia of the equine lower limb: a comparison of lidocaine and lidocaine with epinephrine. , 2004, Tijdschrift voor diergeneeskunde.

[6]  Tomohiro Kato,et al.  Neoantigens in osteoarthritic cartilage. , 2004, Current opinion in rheumatology.

[7]  B. Hinz,et al.  Pain and osteoarthritis: new drugs and mechanisms , 2004, Current opinion in rheumatology.

[8]  L. Bradley.  Recent approaches to understanding osteoarthritis pain. , 2004, The Journal of rheumatology. Supplement.

[9]  H. Schaible,et al.  Pathophysiology of pain , 2004, Langenbeck's archives of surgery (Print).

[10]  P. R. van Weeren,et al.  Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses. , 2004, American journal of veterinary research.

[11]  D. Eyre,et al.  Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. , 2004, Arthritis and rheumatism.

[12]  J. Martel-Pelletier.  Pathophysiology of osteoarthritis. , 1998, Osteoarthritis and cartilage.

[13]  P. Sacerdote,et al.  Effects of tramadol on synovial fluid concentrations of substance P and interleukin-6 in patients with knee osteoarthritis: comparison with paracetamol. , 2003, International immunopharmacology.

[14]  Alexander Fraser,et al.  Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. , 2003, Arthritis and rheumatism.

[15]  T. Nojima,et al.  Bradykinin Expression in Synovial Tissues and Synovial Fluids Obtained from Patients with Internal Derangement of the Temporomandibular Joint , 2003, Cranio : the journal of craniomandibular practice.

[16]  P. Reboul,et al.  Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling , 2003, Current opinion in rheumatology.

[17]  G. Jay,et al.  Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix. , 2003, Osteoarthritis and cartilage.

[18]  P. Delmas,et al.  Biomarkers in osteoarthritis , 2003, Current opinion in rheumatology.

[19]  M. Markel,et al.  Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. , 2002, Osteoarthritis and cartilage.

[20]  H. Schaible.  Mechanisms of pain in arthritis , 2002, Annals of the New York Academy of Sciences.

[21]  B. Caterson,et al.  Cartilage-derived biomarkers of osteoarthritis in synovial fluid of dogs with naturally acquired rupture of the cranial cruciate ligament. , 2002, American journal of veterinary research.

[22]  M. Attur,et al.  Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. , 2002, Osteoarthritis and cartilage.

[23]  A. Bertone,et al.  Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. , 2001, Veterinary surgery : VS.

[24]  P. Dieppe,et al.  Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. , 2001, Osteoarthritis and cartilage.

[25]  W. Rand,et al.  Concentrations of substance P and prostaglandin E2 in synovial fluid of normal and abnormal joints of horses. , 2000, American journal of veterinary research.

[26]  A. Poole,et al.  Alterations in cartilage type‐ii procollagen and aggrecan contents in synovial fluid in equine osteochondrosis , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  K. Brandt,et al.  Synovial fluid glycosaminoglycan concentration does not correlate with severity of chondropathy or predict progression of osteoarthritis in a canine cruciate deficiency model. , 2000, The Journal of rheumatology.

[28]  D. Frisbie,et al.  Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. , 1999, American journal of veterinary research.

[29]  P. Dieppe,et al.  Evidence for altered synthesis of type II collagen in patients with osteoarthritis. , 1998, The Journal of clinical investigation.

[30]  P. R. van Weeren,et al.  Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis , 1998, Annals of the rheumatic diseases.

[31]  A. Barneveld,et al.  Experimental model of synovitis/capsulitis in the equine metacarpophalangeal joint. , 1998, American journal of veterinary research.

[32]  W. Muir,et al.  Cell trafficking, mediator release, and articular metabolism in acute inflammation of innervated or denervated isolated equine joints. , 1998, American journal of veterinary research.

[33]  P. Dieppe,et al.  Generation of kinins in synovial fluid from patients with arthropathy. , 1997, Immunopharmacology.

[34]  A. Nixon,et al.  Distributional changes in substance P nociceptive fiber patterns in naturally osteoarthritic articulations. , 1997, The Journal of rheumatology.

[35]  J. Pritchett.  Substance P level in synovial fluid may predict pain relief after knee replacement. , 1997, The Journal of bone and joint surgery. British volume.

[36]  G. Pijanowski,et al.  Magnetic resonance imaging of degenerative joint disease in a horse: a comparison to other diagnostic techniques. , 1996, Equine veterinary journal.

[37]  S. Kamerling,et al.  Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. , 1996, American journal of veterinary research.

[38]  J. Frölich,et al.  Catalytic hydrogenation of leukotriene B4 enhances sensitivity and specificity of gas chromatography-tandem mass spectrometry techniques and enables simultaneous analysis with cysteinyl leukotrienes in biological fluids. , 1996, Analytical biochemistry.

[39]  A. Barneveld,et al.  The diagnostic nerve block of the sesamoidean nerve: desensitized structures and possible clinical applications. , 1996, The Veterinary quarterly.

[40]  R. Hooke,et al.  Prostaglandin E2 in equine joint disease , 1994 .

[41]  J. Cummings,et al.  Substance P immunohistochemical study of the sensory innervation of normal subchondral bone in the equine metacarpophalangeal joint. , 1994, American journal of veterinary research.

[42]  J. Frölich,et al.  Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[43]  R. M. Bowker,et al.  Substance P innervation of equine synovial membranes: joint differences and neural and nonneural receptor localizations , 1993, Neuroscience Letters.

[44]  R. M. Bowker,et al.  Neuropeptidergic innervation of equine synovial joints. , 1993, American journal of veterinary research.

[45]  M. Shepherd,et al.  Failure of intra-articular anaesthesia of the antebrachiocarpal joint to abolish lameness associated with chip fracture of the distal radius. , 1993, Equine veterinary journal.

[46]  R. M. Bowker,et al.  Substance P in the synovial membrane and fluid of the equine middle carpal joint. , 1992, Equine veterinary journal.

[47]  S. Carter,et al.  Glycosaminoglycans in horses with osteoarthritis. , 1991, Equine veterinary journal.

[48]  D. Buttle,et al.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. , 1986, Biochimica et biophysica acta.

[49]  S. Dyson.  Problems associated with the interpretation of the results of regional and intra-articular anaesthesia in the horse , 1986, Veterinary Record.

[50]  P D Rossdale,et al.  Epidemiological study of wastage among racehorses 1982 and 1983 , 1985, Veterinary Record.

[51]  M. Moskowitz,et al.  Intraneuronal substance P contributes to the severity of experimental arthritis. , 1984, Science.

[52]  T. Glant,et al.  Experimental arthritis produced by proteoglycan antigens in rabbits. , 1980, Scandinavian journal of rheumatology.

[53]  S. Iwanaga,et al.  Occurrence of Leu-Lys-bradykinin and histidine-rich peptide in high-molecular-weight kininogen isolated from horse plasma. , 1979, Biochimica et biophysica acta.

[54]  W. Lergier,et al.  Isolierung und Aminosäuresequenz von Substanz P aus Pferdedarm , 1973 .